• June 16-19, 2025
  • Boston Convention & Exhibition Center

Sessions

Loading

AUM Biosciences

Wednesday, June 05, 2024
Company Presentation
Oncology
Company Presentation Theater 2
AUM is a global clinical-stage oncology company focused on advancing a pipeline of precision therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance. AUM has pipeline of four distinct programs by leveraging its portfolio-driven strategy. AUM advances and grows a portfolio of innovative, early-stage oncology assets based on the latest scientific breakthroughs Specific areas of focus include immuno-oncology, Innate immunity to address significant unmet medical need, including paediatric and orphan cancers. The management team has an extensive track record of selecting distinctive early-stage assets, successfully exiting virtual biotech models, including a $145M USD virtual biotech model with Eisai Pharmaceuticals.
Speakers
Vishal Doshi
CEO
AUM Biosciences
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS